Did you know Wall Street sell ratings can be a better place to look for buy ideas than buy ratings? According to analysis from Trivariate Research, over the past 25 years, the best stock returns were concentrated in the “least loved stocks.” The main takeaway from the analysis was “sell-side ratings are mostly useless.”

This takeaway should not surprise our regular readers. As CEO David Trainer noted in a recent webinar, “the last thing they [Wall Street] want to do is alienate or hurt the relationship with the company.”

It doesn’t have to be this way though.

The best way to get an edge is diligence. We analyze the footnotes of company filings to find material gains and losses that we use to calculate a better measure of earnings and provide proven-superior fundamental research. This diligence allows us to build a stock rating system that outperforms human analysts.

Want real-time proof? Look no further than the performance of the Bloomberg New Constructs Ratings VA-1 Index (ticker: BNCVA1T:IND), managed by Bloomberg, vs. the S&P 500. This index tracks the stocks in the Bloomberg 1000 Index that earn our Very Attractive Rating. From January 1 to March 27, 2025, the Bloomberg New Constructs Ratings VA-1 Index (ticker: BNCVA1T:IND) is up 5.0% while the S&P 500 is down 3.2%.

Don’t base your decisions on Wall Street’s biased ratings, base them on fundamental research you can trust.

We take pride in our diligence, and our work speaks for itself.

Here are the highlights from this week’s research.

Our latest IPO report focuses on CoreWeave, which represents the next way to buy into booming demand for AI.  Buyer beware though. Even after the company lowered its IPO price, it’s still too expensive. Read the full report to see all the red flags we found in CoreWeave’s S-1.

Our Danger Zone pick is a company that is not only losing customers but also continues to lose money in an otherwise profitable industry. Worst of all, it remains a Zombie Stock.

Our CEO, David Trainer, hosted two special webinars this week. The first webinar pits BYD vs. Tesla to see which stock, if either, is worth owning. In the second webinar David provides insights about how the market is shifting to be more efficient while the meme-stock movements may be coming to a halt.

FREE STOCK pick: we published the fifth Footnotes Season report this week, in which we highlighted an undervalued gem that generates more profit than you may realize. These reports are normally available to Pro or higher members, but as a special bonus, we made this report, and the Very Attractive stock featured in it, free for all readers.

On the Model Portfolio front, we published the latest Dividend Growth Stocks Model Portfolio for March.

Links to all our newly published research are below along with a preview for next week’s research.

We hope you have a great week!

IPO Report: Valuation Rotten to the Core

See the red flags in the latest high-profile IPO.

Danger Zone: Way More Downside Left in This Stock

Members can read the latest Danger Zone here.

An Undervalued Gem Upgraded During 10-K Filing Season

Special Webinar Replays

The Next Market Shift Is Already Happening

Earnings Recap on BYD Vs. Tesla

Dividend Growth Stocks Model Portfolio Update for March

Danger Zone Podcast: 3/17/25: Why This Insurance Provider is Back in the Danger Zone

Upcoming Research